D Boesch

757 total citations
10 papers, 629 citations indexed

About

D Boesch is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, D Boesch has authored 10 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in D Boesch's work include Drug Transport and Resistance Mechanisms (5 papers), Synthesis and bioactivity of alkaloids (3 papers) and Cancer therapeutics and mechanisms (3 papers). D Boesch is often cited by papers focused on Drug Transport and Resistance Mechanisms (5 papers), Synthesis and bioactivity of alkaloids (3 papers) and Cancer therapeutics and mechanisms (3 papers). D Boesch collaborates with scholars based in Switzerland, Austria and France. D Boesch's co-authors include Francis Loor, Claire Gavériaux‐Ruff, B Jachez, A Pourtier-Manzanedo, Pietro Bollinger, M. A. Grassberger, René Traber, Roland M. Wenger, Peter Hiestand and T.G. Payne and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Cancer and Experimental Cell Research.

In The Last Decade

D Boesch

10 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Boesch Switzerland 8 513 319 180 116 72 10 629
B Jachez France 9 409 0.8× 223 0.7× 134 0.7× 89 0.8× 60 0.8× 15 533
Marie Stupecky United States 8 435 0.8× 326 1.0× 93 0.5× 88 0.8× 50 0.7× 10 562
Michael M. Gottesman United States 11 367 0.7× 289 0.9× 118 0.7× 94 0.8× 62 0.9× 13 533
Megumi Yoshikawa Japan 9 493 1.0× 288 0.9× 133 0.7× 86 0.7× 64 0.9× 13 574
Peter Hafkemeyer Germany 14 252 0.5× 300 0.9× 86 0.5× 144 1.2× 44 0.6× 22 604
Henricus J. Broxterman Netherlands 13 531 1.0× 358 1.1× 146 0.8× 70 0.6× 84 1.2× 18 625
Kazumi Sano Japan 12 386 0.8× 301 0.9× 94 0.5× 67 0.6× 45 0.6× 29 585
Ellen Friche Denmark 16 496 1.0× 500 1.6× 53 0.3× 44 0.4× 30 0.4× 28 733
Maria A.J. van Eijndhoven Netherlands 7 356 0.7× 258 0.8× 77 0.4× 52 0.4× 45 0.6× 8 520
Csilla Özvegy Hungary 7 541 1.1× 264 0.8× 177 1.0× 127 1.1× 133 1.8× 8 619

Countries citing papers authored by D Boesch

Since Specialization
Citations

This map shows the geographic impact of D Boesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Boesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Boesch more than expected).

Fields of papers citing papers by D Boesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Boesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Boesch. The network helps show where D Boesch may publish in the future.

Co-authorship network of co-authors of D Boesch

This figure shows the co-authorship network connecting the top 25 collaborators of D Boesch. A scholar is included among the top collaborators of D Boesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Boesch. D Boesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Gillet, Ludovic, Kenji Namoto, Sjouke Hoving, et al.. (2008). In-cell Selectivity Profiling of Serine Protease Inhibitors by Activity-based Proteomics. Molecular & Cellular Proteomics. 7(7). 1241–1253. 36 indexed citations
2.
Grassberger, M. A., et al.. (1994). Derivatives of a Novel Cyclopeptolide. 2. Synthesis, Activity against Multidrug Resistance in CHO and KB Cells in vitro, and Structure-Activity Relationships. Journal of Medicinal Chemistry. 37(13). 1918–1928. 13 indexed citations
3.
Boesch, D & Francis Loor. (1994). Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents. Anti-Cancer Drugs. 5(2). 229–238. 22 indexed citations
5.
Jachez, B, et al.. (1994). SDZ 280–125. Anti-Cancer Drugs. 5(3). 313–320. 2 indexed citations
6.
Jachez, B, D Boesch, M. A. Grassberger, & Francis Loor. (1993). Reversion of the P-glycoprotein-mediated multidrug resistance of cancer cells by FK-506 derivatives. Anti-Cancer Drugs. 4(2). 223–230. 16 indexed citations
7.
9.
Boesch, D, Claire Gavériaux‐Ruff, B Jachez, et al.. (1991). In vivo circumvention of P-glycoprotein-mediated multidrug resistance of tumor cells with SDZ PSC 833.. PubMed. 51(16). 4226–33. 322 indexed citations
10.
Gavériaux‐Ruff, Claire, D Boesch, Pietro Bollinger, et al.. (1989). Overcoming multidrug resistance in Chinese hamster ovary cells in vitro by cyclosporin A (Sandimmune) and non-immunosuppressive derivatives. British Journal of Cancer. 60(6). 867–871. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026